Cargando…

Hepatic pyruvate and alanine metabolism are critical and complementary for maintenance of antioxidant capacity and resistance to oxidative insult

OBJECTIVE: Mitochondrial pyruvate is a critical intermediary metabolite in gluconeogenesis, lipogenesis, and NADH production. As a result, the mitochondrial pyruvate carrier (MPC) complex has emerged as a promising therapeutic target in metabolic diseases. Clinical trials are currently underway. How...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yiew, Nicole K.H., Vazquez, Joel H., Martino, Michael R., Kennon-McGill, Stefanie, Price, Jake R., Allard, Felicia D., Yee, Eric U., Layman, Alexander J., James, Laura P., McCommis, Kyle S., Finck, Brian N., McGill, Mitchell R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10561123/ https://www.ncbi.nlm.nih.gov/pubmed/37716594 http://dx.doi.org/10.1016/j.molmet.2023.101808

Ejemplares similares

Treating Hepatic Steatosis and Fibrosis by Modulating Mitochondrial Pyruvate Metabolism
por: McCommis, Kyle S., et al.
Publicado: (2018)

The Hepatic Mitochondrial Pyruvate Carrier as a Regulator of Systemic Metabolism and a Therapeutic Target for Treating Metabolic Disease
por: McCommis, Kyle S., et al.
Publicado: (2023)

Treating fatty liver disease by modulating mitochondrial pyruvate metabolism
por: Colca, Jerry R., et al.
Publicado: (2017)

Extrahepatic toxicity of acetaminophen: critical evaluation of the evidence and proposed mechanisms
por: Kennon-McGill, Stefanie, et al.
Publicado: (2017)

Mitochondrial pyruvate carrier inhibition initiates metabolic crosstalk to stimulate branched chain amino acid catabolism
por: Ferguson, Daniel, et al.
Publicado: (2023)

Identification of Novel Mitochondrial Pyruvate Carrier Inhibitors by Homology Modeling and Pharmacophore-Based Virtual Screening
por: Hegazy, Lamees, et al.
Publicado: (2022)

An ancestral role for the mitochondrial pyruvate carrier in glucose-stimulated insulin secretion
por: McCommis, Kyle S., et al.
Publicado: (2016)

Silencing alanine transaminase 2 in diabetic liver attenuates hyperglycemia by reducing gluconeogenesis from amino acids
por: Martino, Michael R., et al.
Publicado: (2022)

Silencing alanine transaminase 2 in diabetic liver attenuates hyperglycemia by reducing gluconeogenesis from amino acids
por: Martino, Michael R., et al.
Publicado: (2022)

Exogenous phosphatidic acid reduces acetaminophen-induced liver injury in mice by activating hepatic interleukin-6 signaling through inter-organ crosstalk
por: Clemens, Melissa M., et al.
Publicado: (2021)

Mitochondrial pyruvate carrier inhibitors improve metabolic parameters in diet-induced obese mice
por: Hodges, Wesley T., et al.
Publicado: (2021)

Two Faces of Pioglitazone: Sorting Out the Roles of its PPARγ Binding Versus Mitochondrial Pyruvate Carrier Inhibition Is Not So Simple
por: Yuan, Liyun, et al.
Publicado: (2021)

55715 Quantification of Neonatal THC Exposure Following Prenatal Marijuana Use
por: Kennon-McGill, Stefanie, et al.
Publicado: (2021)

4022 Recruiting hidden and sensitive populations: methods for recruitment of pregnant women who regularly use cannabinoids
por: Kennon-McGill, Stefanie, et al.
Publicado: (2020)

The past and present of serum aminotransferases and the future of liver injury biomarkers
por: McGill, Mitchell R.
Publicado: (2016)

Editorial: Diabetes and non-alcoholic fatty liver disease: points of physiological and mechanistic intersection and current co-therapeutic approaches
por: Giannoukakis, Nick, et al.
Publicado: (2023)

Meningitis associated with strongyloidiasis in an area endemic for strongyloidiasis and human T-lymphotropic virus-1: a single-center experience in Japan between 1990 and 2010
por: Sasaki, Y., et al.
Publicado: (2013)

Hepatotoxicity of a Cannabidiol-Rich Cannabis Extract in the Mouse Model
por: Ewing, Laura E., et al.
Publicado: (2019)

CESMM4: civil engineering standard method of measurement
por: McGill, Richard
Publicado: (2012)

20th Conference on the Physics and Chemistry of Semiconductor Interfaces
por: McGill, T C
Publicado: (1993)

Challenges of NGO-to-state Referral in the Delivery of HIV Prevention Programs in Ukraine Supported by the Global Fund
por: McGill, Svetlana
Publicado: (2016)

Development of Cell Lines for use in COVID-19 Drug Development and Research
por: McGill, London
Publicado: (2021)

Introduction
por: McGill, Janet
Publicado: (2018)

NADPH and Glutathione Redox Link TCA Cycle Activity to Endoplasmic Reticulum Homeostasis
por: Gansemer, Erica R., et al.
Publicado: (2020)

NADPH and Glutathione Redox Link TCA Cycle Activity to Endoplasmic Reticulum Homeostasis
por: Gansemer, Erica R., et al.
Publicado: (2022)

Safety and Molecular-Toxicological Implications of Cannabidiol-Rich Cannabis Extract and Methylsulfonylmethane Co-Administration
por: Kutanzi, Kristy R., et al.
Publicado: (2020)

MicroRNAs as Signaling Mediators and Biomarkers of Drug- and Chemical-Induced Liver Injury
por: McGill, Mitchell R., et al.
Publicado: (2015)

Biomarkers of mitotoxicity after acute liver injury: Further insights into the interpretation of glutamate dehydrogenase
por: McGill, Mitchell R., et al.
Publicado: (2021)

Contrasting model mechanisms of alanine aminotransferase (ALT) release from damaged and necrotic hepatocytes as an example of general biomarker mechanisms
por: Smith, Andrew K., et al.
Publicado: (2020)

Low back disorders : evidence-based prevention and rehabilitation
por: McGill, Stuart, 1957-
Publicado: (2007)

Optimal use of β-blockers in high-risk hypertension: A guide to dosing equivalence
por: McGill, Janet B
Publicado: (2010)

The SGLT2 Inhibitor Empagliflozin for the Treatment of Type 2 Diabetes Mellitus: a Bench to Bedside Review
por: McGill, Janet B.
Publicado: (2014)

Causes of metabolic syndrome and obesity-related co-morbidities Part 1: A composite unifying theory review of human-specific co-adaptations to brain energy consumption
por: McGill, Anne-Thea
Publicado: (2014)

Past and future corollaries of theories on causes of metabolic syndrome and obesity related co-morbidities part 2: a composite unifying theory review of human-specific co-adaptations to brain energy consumption
por: McGill, Anne-Thea
Publicado: (2014)

The epidemiology and treatment of gout
por: McGill, Neil W
Publicado: (2011)

Note on the Antiseptic Dressing of Wounds
por: Fergusson-McGill, Arthur
Publicado: (1878)

Puerperal Convulsions Treated by the Hypodermic Use of Morphine
por: McGill, John D.
Publicado: (1875)

preVIEW: COVID-19
por: McGill, Sarah C.
Publicado: (2023)

Short‐Term Safety of Repeated Acetaminophen Use in Patients With Compensated Cirrhosis
por: McGill, Mitchell R., et al.
Publicado: (2021)

Evidence‐based treatment of hyperglycaemia with incretin therapies in patients with type 2 diabetes and advanced chronic kidney disease
por: Tuttle, Katherine R., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_d4k1ialkh2d95k47kc887thb3q